C12P 19/623
Avermectin
Official title: {Avermectin; Milbemycin; Ivermectin; C-076}
C12P19/623 (Avermectin) appears on 63 US grants and 23 published applications in this corpus.
Search patents in C12P- Granted patents
- 63
- Published applications
- 23
- Assignees
- 19
- Inventors
- 118
- Latest grant
- 2 Jul 2019
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1979 | 4 | 0 |
| 1980 | 3 | 0 |
| 1981 | 1 | 0 |
| 1982 | 2 | 0 |
| 1983 | 3 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 4 | 0 |
| 1992 | 2 | 0 |
| 1993 | 6 | 0 |
| 1994 | 3 | 0 |
| 1995 | 1 | 0 |
| 1996 | 4 | 0 |
| 1997 | 1 | 0 |
| 1998 | 2 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 2 | 2 |
| 2002 | 1 | 0 |
| 2003 | 3 | 6 |
| 2004 | 3 | 1 |
| 2005 | 1 | 3 |
| 2006 | 2 | 0 |
| 2007 | 1 | 0 |
| 2008 | 2 | 1 |
| 2009 | 0 | 3 |
| 2010 | 2 | 0 |
| 2011 | 1 | 0 |
| 2012 | 1 | 0 |
| 2013 | 1 | 2 |
| 2014 | 1 | 0 |
| 2015 | 0 | 2 |
| 2016 | 1 | 0 |
| 2017 | 0 | 1 |
| 2018 | 0 | 0 |
| 2019 | 1 | 0 |
| 2020 | 0 | 1 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Recombinant microorganism expressing avermectin analogue and use thereof2 Jul 2019US 10,334,850 B2Zhejiang Hisun Pharmaceutical Co., Ltd.
- Reversible natural product glycosyltransferase-catalyzed reactions, compounds and related methods18 Oct 2016US 9,469,864 B2Wisconsin Alumni Research Foundation
- Reversible natural product glycosyltransferase-catalyzed reactions, compounds and related methods23 Sep 2014US 8,841,092 B2Wisconsin Alumni Research Foundation
- Dermatological compositions comprising avermectin nanocapsules23 Jul 2013US 8,491,928 B2Galderma S. A.
- Dermatological compositions comprising avermectin nanocapsules13 Nov 2012US 8,309,121 B2Galderma S. A.
- Method for improving production of streptomyces polyketide compounds23 Feb 2023US 2023/0056311 A1East China University of Science and Technology
- Ivermectin b1b producing strain and use thereof30 Apr 2020US 2020/0131552 A1Zhejiang Hisun Pharmaceutical Co., Ltd.
- Recombinant microorganism expressing avermectin analogue and use thereof19 Jan 2017US 2017/0013837 A1Zhejiang Hisun Pharmaceutical Co., Ltd.
- Reversible natural product glycosyltransferase-catalyzed reactions, compounds and related methods21 May 2015US 2015/0141294 A1Wisconsin Alumni Research Foundation
- Microorganism production of high-value chemical products, and related compositions, methods and systems26 Feb 2015US 2015/0056651 A1OPX Biotechnologies, Inc.
Most cited
By later US patents
- Selective hydrogenation products of C-076 compounds and derivatives thereof157US 4,199,569 AMerck & Co., Inc. · 1980
- Novel substances and process for their production150US 4,310,519 AMerck & Co., Inc. · 1982
- Cloning genes from Streptomyces avermitilis for avermectin biosynthesis and the methods for their use69US 5,252,474 AMerck & Co., Inc. · 1993
- Monosaccharide and aglycone derivatives of C-07663US 4,206,205 AMerck & Co., Inc. · 1980
- Non-natural demethylavermectins compositions and method of use61US 5,077,278 APfizer Inc. · 1991